12 Stocks Under $5 With Biggest Upside Potential

Page 11 of 11

1. ImmunityBio, Inc. (NASDAQ:IBRX)

Upside Potential: 314.63%

Stock Price as of January 17: $2.94

Number of Hedge Fund Investors: 8

ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company developing treatments for cancer and infectious diseases. The company combines cell therapy, immunomodulators, and vaccine technology to enhance the immune system’s ability to fight diseases.

ImmunityBio, Inc. (NASDAQ:IBRX) is focusing on the successful commercialization of its flagship product Anktiva (nogapendekin alfa), an interleukin-15 receptor superagonist, that was approved by the FDA in April 2024 for the treatment of bladder cancer in combination with BCG (Bacillus Calmette-Guérin). The company has implemented a comprehensive commercialization strategy for Anktiva, focusing on building a strong sales and marketing team, establishing a reliable distribution network, and implementing patient support programs to ensure that Anktiva is accessible to patients and healthcare providers.

Additionally, ImmunityBio, Inc. (NASDAQ:IBRX) is expanding Anktiva’s market in other bladder and lung cancers along with other solid tumors. The company is preparing to submit a supplemental application in the United States to extend the drug’s approval to include patients with papillary bladder cancer, a broader patient population than the currently approved indication. ImmunityBio, Inc. (NASDAQ:IBRX) is also expanding its market reach by pursuing approvals in other regions such as Europe and the UK.

While we acknowledge the potential of ImmunityBio, Inc. (NASDAQ:IBRX) to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than IBRX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 11 of 11